Clarivate will monitor, manage, and maintain Company’s expanding IP portfolio ENGLEWOOD CLIFFS, NJ, Aug. 10, 2023 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, announced today that it has retained the services of Clarivate, a leading global provider of…


Previous articleExploring the Vast Potential of Psychedelic Medicine: A Physician’s Perspective on Allopathy, Virtual Community, and Clinical Research
Next articleOptimi Health Announces CAD $3,000,000 Senior Debt Financing